FDA-2024-0041-V141
Major variation for application FDA-2024-0041. Major variation: Facility Change for Lorlatenilib — critical change
Variation Number
FDA-2024-0041-V141
Type
Major
Application
Change
Status
Completed
Fee
€20,712
Submitted
2024-02-09
Approved
—
Description
Major variation: Facility Change for Lorlatenilib — critical change